Bacillus subtilis

枯草杆菌

Report date: 2024/09/06 14:51:39

Base Information

Drug NameBacillus subtilis
Drug Alias NameN/A
ClassificationBiologics > Live Biotherapeutic
Mechanisms of ActionBacteria replacements
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Helicobacter pylori infectionDiarrhea +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesIranMacau +[4] 
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaN/A
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesDeerland EnzymesLipscomb UniversityXiamen Hospital, Zhongshan Hospital Affiliated To Fudan University +[6] 
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)Helicobacter pylori infectionDiarrhea +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksWikipedia